PReS-FINAL-1016: Micro vesicles as a magnifying glass; uncovering potential biomarkers in juvenile idiopathic arthritis
نویسندگان
چکیده
Introduction Juvenile idiopathic arthritis (JIA) is a common chronic inflammatory diseases in childhood. Despite remission as a result of a plethora of treatment techniques, the chronic and relapsing nature of the disease requires continuous treatment which causes adverse side effects. It is important to uncover a biomarker that can efficiently predict patient responses to therapy as well as determine if patients will progress or regress as a result of treatment. Micro vesicles are key messengers containing many immune signaling molecules including cytokines, molecules known to play a major role in JIA.
منابع مشابه
PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy
PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy N Nirmala, N Wulffraat, H Brunner, P Quartier, R Brik, L Mccann, H Ozdogan, L Rutkowska-Sak, R Schneider, V Gerloni, L Harel, M Terreri, K Houghton, R Joos, D Kingsbury, J Lopez-Benitez, S Radominski, A Brachat, S Bek, M Schumacher, M Valentin...
متن کاملPReS-FINAL-2216: Biomarkers MRP8/14 and S100A12 correspond with flare and remission clinical status in Sojia patients in the AID-NET register
Introduction Systemic onset juvenile idiopathic arthritis (SoJIA) shows properties of autoinflammatory disease, and requires the presence of arthritis and fever for diagnosis. The proinflammatory proteins MRP8/14 (S100A8/9) and S100A12 are biomarkers which have been shown to detect ongoing subclinical disease activity in patients with clinical remission. We compared the MRP8/14 (S100A8/9) and S...
متن کاملPReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
Introduction The outcome of children with juvenile idiopathic arthritis (JIA) has improved over the last decades. However, the disease course is still not easy to predict, especially based on traditional clinical factors. In the German prospective controlled observational multicentre study ICON-JIA (Inception Cohort Of Newly-diagnosed patients with JIA) patients with diagnosis of JIA <12 months...
متن کاملPReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial C Malattia, N Ruperto, E Palmisani, S Pederzoli, A Pistorio, HI Brunner, R Cuttica, I Calvo, SM Garay, D Eleftheriou, C Wouters, J Wang, C Devlin, D Lovell, A Martini, F De Benedetti, A Ravelli, PRCSG an...
متن کاملPReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register MH Otten, J Anink, FH Prince, M Twilt, SJ Vastert, R Ten Cate, EP Hoppenreijs, W Armbrust, SL Gorter, PA Van Pelt, S Kamphuis, KM Dolman, JF Swart, JM Van den Berg, Y Koopman-Keemink, MA Van Rossum, NM Wulffraat, LA Van ...
متن کامل